Financial statements Beta-Bio
Balance sheet of Beta-Bio
Company age:
Age:
12 y. 8 m. 7 d.
Share capital:
Share capital:
5 000 PLN
Company suspended its operations from 2024-06-20
Balance sheet data of BETA-BIO
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 70 220,44 | 55 335,38 |
| A. Fixed assets | 17 837,93 | 17 837,93 |
| B. Current assets | 52 382,51 | 37 497,45 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 70 220,44 | 55 335,38 |
| A. Equity | 3 938,45 | 13 245,59 |
| B. Liabilities and provisions for liabilities | 66 281,99 | 42 089,79 |
| I. Long-term liabilities | - | - |
| II. Short-term liabilities | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.